Oregon Opioid Settlement Funds
Since July 2021, the State of Oregon has reached agreement on national lawsuits against several companies for their role in the opioid crisis. Through these agreements, nearly $600 million will be awarded to Oregon over the course of 18 years.
As of February 2024, funds have been received from:
- Distributor Settlement payments (settlements between the State of Oregon and participating subdivisions and McKesson, Cardinal and AmerisourceBergen)
- Janssen Settlement payments (settlement between the State of Oregon and participating subdivisions and Johnson & Johnson, Janssen Pharmaceuticals, Incorporated, and Ortho-McNeil-Janssen Pharmaceuticals, Incorporated)
- Mallinckrodt payments (settlement between the State of Oregon and participating subdivisions and Mallinckrodt Pharmaceuticals)
- Additional restitution funds from Oregon Department of Justice
Additional payments are pending from settlements with Teva, Allergan, CVS, Walgreens, Walmart, Kroger and Publicis.
These funds can be used for a wide variety of opioid prevention, treatment, and recovery strategies
(Exhibit E Approved Uses).
Settlement funds from opioid manufacturers, distributors, and pharmacies are divided between the State of Oregon (45%) and local jurisdictions (55%) pursuant to
Oregon's intrastate allocation agreements. The state’s share is deposited as it becomes available into the Opioid Settlement, Prevention, Treatment and Recovery (OSPTR) Fund required by
ORS Chapter 63, Sections 5-10. This fund is controlled by the 18-member
Oregon Opioid Settlement Prevention, Treatment and Recovery Board. Oregon Health Authority provides staff support to the OSPTR Fund and Board.
Throughout the current fiscal biennium which ends in June 2025, approximately $89 million will be deposited into the OSPTR Fund. To date, the OSPTR Board has decided upon the following allocations:
- $26.7 million to the nine
Federally Recognized Tribes in Oregon – this is equivalent to 30% of all funds anticipated this biennium. This 30% set-aside will continue throughout the life of the fund as additional settlement payments are deposited.
- $13 million to the
Save Lives Oregon Harm Reduction Clearinghouse, to distribute naloxone and other life-saving supplies to qualified entities.
- $4 million to develop a unified and evidence-based state system for collecting, analyzing and publishing data about the availability and efficacy of substance use prevention, treatment and recovery services in Oregon as required by
ORS Chapter 63, Section 6.
Additional allocation decisions are expected during this biennium, which ends in June 2025.
- The OSPTR Board will allocate the remainder of the funds across eight categories:
- Harm reduction and overdose prevention: 22%
- Primary prevention: 22%
- Treatment: 21%
- Recovery: 21%
- Research and evaluation: 3%
- Leadership, planning, and coordination: 6%
- Emerging issues: 2%
- Administrative costs: 2%
ORS Chapter 63, Section 6 allows up to 5% of the OSPTR Fund to go to administrative expenses such as staffing, fund management, contracts, and grants management. A total of $1.3 million has been set aside for administrative expenses to date.
For more information, please refer to the National opioid settlements website.
For questions contact Interim Opioid Settlement Manager, Lisa Shields
Oregon Health Authority, Public Health Division
Injury and Violence Prevention Program
Work cell phone: (971) 258-4995
The opioid settlement funds will be divided between the State of Oregon (45%) and local jurisdictions (55%).
Subdivision Fund: Distributed Directly to Cities and Counties
Cities and counties in Oregon with populations greater than 10,000 will receive 55% of the opioid settlement funds. At this time, the total distribution to the Subdivision Fund is approximately $178 million, or 55% of the Oregon settlement funds. This portion of the funds will be divided among cities and counties using a population-based model developed through the settlement agreement (Exhibit A).
Local jurisdictions will decide how their funds are used. Cities and counties will be required to report to the Oregon Department of Justice annually on how they have allocated their funds. The annual reports will be publicly available, and the State will host a public meeting to discuss each annual report. This webpage will provide information about these public meetings.
Oregon Opioid Settlement Prevention, Treatment, and Recovery Fund: Distributed to the State
The State of Oregon will receive 45% of the total opioid settlement funds. The Oregon State Legislature passed
House Bill 4098
in March 2022 to dictate how the State will manage and allocate these funds for statewide and regional opioid prevention, treatment, and recovery strategies.
House Bill 4098 mandates that an 18-member advisory board will determine how State’s portion of the funds will be allocated. These funding decisions will be in alignment with Oregon's Strategic Plan for Substance Use Services. A portion of the State’s funds must be used towards a unified and evidence-based state system for collecting, analyzing, and publishing data about the availability and efficacy of substance use prevention, treatment, and recovery services statewide.
The Oregon Health Authority is collaborating closely with the Governor’s Office, the Oregon Department of Justice, and the Alcohol and Drug Policy Commission to implement the activities outlined in the opioid settlement agreement and House Bill 4098. These agencies are currently laying the groundwork to form the OSPTR Board, which is expected to begin meeting in late Fall 2022.
Approximately $503 million is going directly to federally recognized tribes from the
Distributor and Janssen Settlement Agreements.
All federally recognized tribes are eligible to participate in the tribal Opioid Settlements, regardless of whether a tribe filed an opioid lawsuit. Oregon's nine federally recognized tribes are eligible to receive a portion of the $503 million settlement.
Refer to the Tribal Opioid Settlements webpage for more information:
House Bill 4098 mandates that an 18-member Opioid Settlement Prevention, Treatment and Recovery (OSPTR) Board will determine how to allocate the State’s portion of the opioid settlement funds for statewide and regional opioid prevention, treatment, and recovery initiatives. These funding decisions will be in alignment with
Oregon's Strategic Plan for Substance Use Services.
The OSPTR Board will host a series of public meetings and will provide community members the opportunity to provide testimony and input. The Board will also establish a process for the public to provide written comments and proposals at each Board meeting. This webpage will provide information about the public process and meetings.
If you would like to submit a letter or statement to the OSPTR Board, please send it to Lisa.email@example.com.
Learn more at the OSPTR Board webpage.
OSPTR Board Timeline (click here to enlarge)